title: Gastropleural fistula in a patient with recurrent ovarian cancer receiving combination therapy with Carboplatin, gemcitabine, and bevacizumab.
authors.affiliation: University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
authors.forename: Thorsten
authors.initials: T
authors.lastname: Dohrmann
authors.forename: Asad
authors.initials: A
authors.lastname: Kutup
authors.forename: Sven
authors.initials: S
authors.lastname: Mahner
authors.forename: Volkmar
authors.initials: V
authors.lastname: Müller
authors.forename: Fritz
authors.initials: F
authors.lastname: Jaenicke
authors.forename: Jacob R
authors.initials: JR
authors.lastname: Izbicki
authors.forename: Yogesh K
authors.initials: YK
authors.lastname: Vashist
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D000068258:Bevacizumab; D016190:Carboplatin / Q000008:administration & dosage; D000077216:Carcinoma, Ovarian Epithelial; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D005747:Gastric Fistula / Q000139:chemically induced* / Q000473:pathology / Q000601:surgery; D006801:Humans; D007412:Intestinal Fistula / Q000139:chemically induced* / Q000473:pathology / Q000601:surgery; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology; D009375:Neoplasms, Glandular and Epithelial / Q000150:complications / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy*; D000093542:Gemcitabine
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D003841:Deoxycytidine; D000068258:Bevacizumab; D016190:Carboplatin; D000093542:Gemcitabine